Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism
Public ClinicalTrials.gov record NCT00123461. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Study to Assess the Efficacy and Safety of Doxercalciferol Capsules in Vitamin D-replete Subjects With Chronic Kidney Disease (CKD) Stages 3 or 4 With Secondary Hyperparathyroidism (SHPT).
Study identification
- NCT ID
- NCT00123461
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Genzyme, a Sanofi Company
- Industry
- Enrollment
- 70 participants
Conditions and interventions
Interventions
- Hectorol (doxercalciferol capsules), 0.5mcg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2005
- Primary completion
- Sep 30, 2007
- Completion
- Sep 30, 2007
- Last update posted
- May 4, 2015
2005 – 2007
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AKDHC Medical Research Services | Phoenix | Arizona | 85012 | — |
| UCLA Diabetes Reseach Center | Alhambra | California | — | — |
| Apex Research of Riverside | Riverside | California | 92501 | — |
| George Washington University Hospital | Washington D.C. | District of Columbia | 20037 | — |
| Discovery Medical Research Group | Ocala | Florida | 34471 | — |
| Nephrology Associates | Palm Beach Gardens | Florida | 33410 | — |
| Georgia Kidney Associates, Inc. | Marietta | Georgia | 30060 | — |
| Michigan Kidney Consultants, P.C. | Pontiac | Michigan | 48341 | — |
| Twin Cities Clinical Research | Brooklyn Center | Minnesota | 55430 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Montefiore Medical Center | The Bronx | New York | — | — |
| Wake Nephrology Associates, PA | Raleigh | North Carolina | — | — |
| Wake Forest University School of Medicine | Winston-Salem | North Carolina | — | — |
| Altru Health System Research Center | Grand Forks | North Dakota | 58201 | — |
| DaVita Lewiston Dialysis Center | Lewiston | Pennsylvania | 17044 | — |
| Temple University | Philadelphia | Pennsylvania | — | — |
| Virginia Commonwealth University | Richmond | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00123461, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2015 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00123461 live on ClinicalTrials.gov.